Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSStandard

EPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE

EPINEPHRINE BITARTRATE

Standard Dose
EQ 16MG BASE/250ML (EQ 64MCG BASE/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: N/A Marketing status: Prescription
Summary

Approval overview EPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE is listed in Drugs@FDA under application 218475 (NDA).

Review priority: N/A Marketing status: Prescription Active ingredient EPINEPHRINE BITARTRATE Form and strength SOLUTION;INTRAVENOUS - EQ 16MG BASE/250ML (EQ 64MCG BASE/ML) Sponsor BAXTER HLTHCARE CORP Submission history Latest submission status date: 2025-09-29 00:00:00.

Structured Monograph

Clinical summary

Approval overview EPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE is listed in Drugs@FDA under application 218475 (NDA). Review priority: N/A Marketing status: Prescription Active ingredient EPINEPHRINE BITARTRATE Form and strength SOLUTION;INTRAVENOUS - EQ 16MG BASE/250ML (EQ 64MCG BASE/ML) Sponsor BAXTER HLTHCARE CORP Submission history Latest submission status date: 2025-09-29 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: N/A

Interaction Notes

  • No interaction notes stored yet.
EPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE (EPINEPHRINE BITARTRATE) | Drug Monograph | MedicHelpline